SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001571049-17-008053
Filing Date
2017-09-29
Accepted
2017-09-29 16:10:28
Documents
4
Period of Report
2017-10-26
Effectiveness Date
2017-09-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT t1702657-def14a.htm DEF 14A 457965
2 GRAPHIC lg_oncobiologics.jpg GRAPHIC 118526
3 GRAPHIC t1702657_pc1.jpg GRAPHIC 319337
4 GRAPHIC t1702657_pc2.jpg GRAPHIC 238982
  Complete submission text file 0001571049-17-008053.txt   1391545
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Oncobiologics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-37759 | Film No.: 171111625
SIC: 2836 Biological Products, (No Diagnostic Substances)